6 withdrawn. 6 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Withdrawn 6 |
| Phase 3 | 1 | Withdrawn 1 |
Follow Type 1 Diabetes: new trials by email Literature Review of Type 1 Diabetes trials Research Report on Type 1 Diabetes
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Closed-loop Control of Glucose Levels (Artificial Pancreas) for 5 Days in Adults With Type 1 Diabetes 5-day intervention with single-hormone closed-loop strategy, 5-day intervention with sensor-augmented pump therapy, Insulin pump - Type 1 Diabetes | Phase 2 | Withdrawn | Institut de Recherches Cliniques de Montreal | 2018-03-01 | 2018-01-31 | |
| Closed-loop Control of Postprandial Glucose Levels in Children and Adults With Type 1 Diabetes 6-day intervention with sensor-augmented pump therapy, 6-day intervention with single-hormone closed-loop strategy, 6-day intervention with dual-hormone closed-loop strategy - Type 1 Diabetes | Phase 2 | Withdrawn | Institut de Recherches Cliniques de Montreal | 2018-01-01 | 2017-10-27 | |
| Autologous Immunoregulatory Dendritic Cells for Type 1 Diabetes Therapy Immunoregulatory Dendritic Cells, Placebo Comparator: Placebo Control - Type 1 Diabetes | Phase 2 | Withdrawn | DiaVacs, Inc. | 2015-10-01 | 2024-02-20 | |
| Efficacy of Small Subcutaneous Glucagon Dose to Treat Hypoglycemia in Adults With Type 1 Diabetes Hypoglycaemic hyperinsulinemic clamp, Glucagon - Type 1 Diabetes | Phase 2 | Withdrawn | Institut de Recherches Cliniques de Montreal | 2013-04-01 | 2013-12-04 | |
| Closed-loop Control of Glucose Levels (Artificial Pancreas) for 15 Weeks in Adolescents and Adults With Type 1 Diabetes 15-week intervention with sensor-augmented pump, 15-week intervention with single-hormone closed-loop, 15-week intervention with dual-hormone closed-loop - Type 1 Diabetes | Phase 2 | Withdrawn | Institut de Recherches Cliniques de Montreal | 2019-07-23 | ||
| DiaCon Dual-Hormone Closed-Loop Glucose Control DiaCon dual-hormone closed-loop glucose control algorithm, DiaCon single-hormone closed-loop glucose control algorithm - Type 1 Diabetes | Phase 2 / Phase 3 | Withdrawn | Hvidovre University Hospital | 2017-08-09 |
Diabetes Mellitus, Type 1 (6) · Hypoglycemia (4) · Insulin Resistance (3)
Autoimmune Diseases (6) · Diabetes Mellitus (6) · Endocrine System Diseases (6) · Glucose Metabolism Disorders (6) · Immune System Diseases (6) · Metabolic Diseases (6) · Nutritional and Metabolic Diseases (6) · Hyperinsulinism (3)
Glucagon (3) · Insulin (3) · Methods (3) · Continuous Glucose Monitoring (2) · Insulin Infusion Systems (2)
Institut de Recherches Cliniques de Montreal (4) · DiaVacs, Inc. (1) · Hvidovre University Hospital (1)
Canada (3) · Denmark (1)
Massimo Trucco, PhD (1) · Signe Schmidt, MD, PhD (1)